Rocket Pharmaceuticals, Inc. Cash
Rocket Pharmaceuticals, Inc. (RCKT) had Cash of $286.90 million as of 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2024-08-06
- 2024-06-30: Cash $286.90M.
- 2024-03-31: Cash $338.90M.
- 2023-12-31: Cash $394.40M.
| Period end | Cash |
|---|---|
| 2024-06-30 | $286.90M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $338.90M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $394.40M 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |